This year could see the first trials of therapies employing base editing that introduce precise single-nucleotide changes into patient genomes.
This is a preview of subscription content, log in via an institution to check access.
Change history
07 June 2022
In the version of this article initially published, the quote in the second paragraph in Box 2 appeared without the contextual text “addressing the similar issue of foreign Cas9 protein,” which has now been amended.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Eisenstein, M. Base editing marches on the clinic. Nat Biotechnol 40, 623–625 (2022). https://doi.org/10.1038/s41587-022-01326-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-022-01326-x
- Springer Nature America, Inc.